Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Cardiovascular Complications of Marijuana and Related Substances: A Review

Cardiovascular Complications of Marijuana and Related Substances: A Review The recreational use of cannabis has sharply increased in recent years in parallel with its legalization and decriminalization in several countries. Commonly, the traditional cannabis has been replaced by potent synthetic cannabinoids and cannabimimetics in various forms. Despite overwhelming public perception of the safety of these substances, an increasing number of serious cardiovascular adverse events have been reported in temporal relation to recreational cannabis use. These have included sudden cardiac death, vascular (coronary, cerebral and peripheral) events, arrhythmias and stress cardiomyopathy among others. Many of the victims of these events are relatively young men with few if any cardiovascular risk factors. However, there are reasons to believe that older individuals and those with risk factors for or established cardiovascular disease are at even higher danger of such events following exposure to cannabis. The pathophysiological basis of these events is not fully understood and likely encompasses a complex interaction between the active ingredients (particularly the major cannabinoid, Δ9-tetrahydrocannabinol), and the endo-cannabinoid system, autonomic nervous system, as well as other receptor and non-receptor mediated pathways. Other complicating factors include opposing physiologic effects of other cannabinoids (predominantly cannabidiol), presence of regulatory proteins that act as metabolizing enzymes, binding molecules, or ligands, as well as functional polymorphisms of target receptors. Tolerance to the effects of cannabis may also develop on repeated exposures at least in part due to receptor downregulation or desensitization. Moreover, effects of cannabis may be enhanced or altered by concomitant use of other illicit drugs or medications used for treatment of established cardiovascular diseases. Regardless of these considerations, it is expected that the current cannabis epidemic would add significantly to the universal burden of cardiovascular diseases. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cardiology and Therapy Springer Journals

Cardiovascular Complications of Marijuana and Related Substances: A Review

Download PDF
15 pages

Loading next page...
 
/lp/springer-journals/cardiovascular-complications-of-marijuana-and-related-substances-a-KHXeTwFArk
Publisher
Springer Journals
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Cardiology
ISSN
2193-8261
eISSN
2193-6544
DOI
10.1007/s40119-017-0102-x
Publisher site
See Article on Publisher Site

Abstract

The recreational use of cannabis has sharply increased in recent years in parallel with its legalization and decriminalization in several countries. Commonly, the traditional cannabis has been replaced by potent synthetic cannabinoids and cannabimimetics in various forms. Despite overwhelming public perception of the safety of these substances, an increasing number of serious cardiovascular adverse events have been reported in temporal relation to recreational cannabis use. These have included sudden cardiac death, vascular (coronary, cerebral and peripheral) events, arrhythmias and stress cardiomyopathy among others. Many of the victims of these events are relatively young men with few if any cardiovascular risk factors. However, there are reasons to believe that older individuals and those with risk factors for or established cardiovascular disease are at even higher danger of such events following exposure to cannabis. The pathophysiological basis of these events is not fully understood and likely encompasses a complex interaction between the active ingredients (particularly the major cannabinoid, Δ9-tetrahydrocannabinol), and the endo-cannabinoid system, autonomic nervous system, as well as other receptor and non-receptor mediated pathways. Other complicating factors include opposing physiologic effects of other cannabinoids (predominantly cannabidiol), presence of regulatory proteins that act as metabolizing enzymes, binding molecules, or ligands, as well as functional polymorphisms of target receptors. Tolerance to the effects of cannabis may also develop on repeated exposures at least in part due to receptor downregulation or desensitization. Moreover, effects of cannabis may be enhanced or altered by concomitant use of other illicit drugs or medications used for treatment of established cardiovascular diseases. Regardless of these considerations, it is expected that the current cannabis epidemic would add significantly to the universal burden of cardiovascular diseases.

Journal

Cardiology and Therapy – Springer Journals

Published: Dec 7, 2017

References

  • The science of marijuana
    Iversen, LL
  • What is the current knowledge about the cardiovascular risk for users of cannabis-based products? A systematic review
    Jouanjus, E; Raymond, V; Lapeyre-Mestre, M; Wolff, V
  • Terpene synthases from Cannabis sativa
    Booth, JK; Page, JE; Bohlmann, J
  • Efficacy and safety of medical marijuana in selected neurologic disorders. Report of the Guideline Development Subcommittee of the American Academy of Neurology
    Koppel, BS; Brust, JC; Fife, T; Bronstein, J; Youssof, S; Gronseth, G; Gloss, D
  • Cannabis and the brain
    Iversen, L
  • Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking
    Ohlsson, A; Lindgren, JE; Wahlen, A
  • Pharmacokinetics and pharmacodynamics of cannabinoids
    Grotenhermen, F
  • Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs
    Gurney, SMR; Scott, KS; Kacinko, SL; Presley, BC; Logan, BK
  • Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms
    Benowitz, NL; Rosenberg, J; Rogers, W; Bachman, J; Jones, RT
  • Effects of smoking marihuana on left ventricular performance and plasma norepinephrine studies in normal men
    Gash, A; Karliner, JS; Janowsky, D; Lake, CR
  • The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade
    Kanakis, C; Pouget, JM; Rosen, KM
  • Marihuana smoking: cardiovascular effects in man and possible mechanisms
    Beaconsfield, P; Ginsburg, J; Rainsbury, R
  • Propranolol effects on acute marihuana intoxication in man
    Sulkowski, A; Vachon, L; Rich, E
  • Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users
    Huestis, MA; Boyd, SJ; Heishman, SJ; Preston, KL
  • Subjective and physiological effects after controlled Sativex and oral THC administration
    Karschner, EL; Darwin, WD; McMahon, RP; Liu, F; Wright, S; Goodwin, RS
  • Safety of oral dronabinol during opioid withdrawal in humans
    Jicha, CJ; Lofwall, MR; Nuzzo, PA; Babalonis, S; Elayi, SC; Walsh, SL
  • Paroxysmal atrial fibrillation after recreational marijuana smoking: another “holiday heart”?
    Charbonney, E; Sztajzel, JM; Poletti, PA; Rutschmann, O
  • Paroxysmal atrial fibrillation following marijuana intoxication: a two-case report of possible association
    Kosior, DA; Filipiak, KJ; Stolarz, P; Opolski, G
  • Atrial fibrillation associated with marijuana use
    Singh, GK
  • Effect of acute marijuana on cardiovascular function and central nervous system pharmacokinetics of [(15)O]water: effect in occasional and chronic users
    Ponto, LL; O’Leary, DS; Koeppel, J
  • Cannabis use and blood pressure levels: United States National Health and Nutrition Examination Survey, 2005–2012
    Alshaarawy, O; Elbaz, HA
  • Effects of marihuana and placebo marihuana smoking on hemodynamics in coronary disease
    Prakash, R; Aronow, WS; Warren, M
  • Short-term effects of smoked marihuana on left ventricular function in man
    Tashkin, DP; Levisman, JA; Abbasi, AS; Shapiro, BJ; Ellis, NM
  • Pulmonary hazards of smoking marijuana as compared with tobacco
    Wu, TC; Tashkin, DP; Djahed, B; Rose, JE
  • Effect of marihuana and placebo-marihuana smoking on angina pectoris
    Aronow, WS; Cassidy, J
  • Ventricular fibrillation triggered by marijuana use in a patient with ischemic cardiomyopathy: a case report
    Baranchuk, A; Johri, AM; Simpson, CS; Methot, M; Redfearn, DP
  • Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1
    Jordt, SE; Bautista, DM; Chuang, HH; McKemy, DD; Zygmunt, PM; Högestätt, ED; Meng, ID; Julius, D
  • Presentations to the emergency department following cannabis use—a multi-centre case series from ten European countries
    Dines, AM; Wood, DM; Galicia, M; Yates, CM; Heyerdahl, F; Hovda, KE
  • Further characterization of the time-dependent vascular effects of delta9-tetrahydrocannabinol
    O’Sullivan, SE; Kendall, DA; Randall, MD
  • Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity
    Quercioli, A; Pataky, Z; Vincenti, G
  • Modulation of cellular redox homeostasis by the endocannabinoid system
    Lipina, C; Hundal, HS
  • Δ(9)-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles
    Williams, JC; Klein, TW; Goldberger, BA; Sleasman, JW; Mackman, N; Goodenow, MM
  • Cannabis and coronary thrombosis: what is the role of platelets?
    Dahdouh, Z; Roule, V; Lognoné, T; Sabatier, R; Grollier, G
  • Cannabis-associated myocardial infarction in a young man with normal coronary arteries
    Hodcroft, CJ; Rossiter, MC; Buch, AN
  • Acute myocardial infarction due to marijuana smoking in a young man: guilty should not be underestimated
    Velibey, Y; Sahin, S; Tanık, O; Keskin, M; Bolca, O; Eren, M
  • The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets
    Deusch, E; Kress, HG; Kraft, B; Kozek-Langenecker, SA
  • Mechanism of platelet activation induced by endocannabinoids in blood and plasma
    Brantl, SA; Khandoga, AL; Siess, W
  • Cannabis use: signal of increasing risk of serious cardiovascular disorders
    Jouanjus, E; Lapeyre-Mestre, M; Micallef, J
  • Cannabis as a precipitant of cardiovascular emergencies
    Lindsay, AC; Foale, RA; Warren, O; Henry, JA
  • Recreational marijuana use: is it safe for your patient?
    Rezkalla, S; Kloner, RA
  • Cardiovascular effects of marijuana
    Rezkalla, S; Stankowski, R; Kloner, RA
  • Triggering myocardial infarction by marijuana
    Mittleman, MA; Lewis, RA; Maclure, M; Sherwood, JB; Muller, JE
  • Public health importance of triggers of myocardial infarction: a comparative risk assessment
    Nawrot, TS; Perez, L; Künzli, N; Munters, E; Nemery, B
  • Marijuana-induced recurrent acute coronary syndrome with normal coronary angiograms
    Safaa, AM; Markham, R; Jayasinghe, R
  • Keep off the grass: marijuana use and acute cardiovascular events
    Caldicott, DG; Holmes, J; Roberts-Thomson, KC; Mahar, L
  • Cannabis-induced coronary artery thrombosis and acute anterior myocardial infarction in a young man
    Tatli, E; Yilmaztepe, M; Altun, G
  • Cannabis: a trigger for acute myocardial infarction? A case report
    Cappelli, F; Lazzeri, C; Gensini, GF
  • Acute myocardial infarction in a young man; fatal blow of the marijuana: a case report
    Yurtdaş, M; Aydın, MK
  • Toxic effects of marijuana on the cardiovascular system
    Pratap, B; Korniyenko, A
  • ST-segment elevation myocardial infarction in a 37-year-old man with normal coronaries—it is not always cocaine!
    Arora, S; Goyal, H; Aggarwal, P; Kukar, A
  • ST segment elevation myocardial infarction due to slow coronary flow occurring after cannabis consumption
    Karabulut, A; Cakmak, M
  • Is recent cannabis use associated with acute coronary syndromes? An illustrative case series
    Casier, I; Vanduynhoven, P; Haine, S; Vrints, C; Jorens, PG
  • Myocardial infarction following cannabis induced coronary vasospasm
    Gunawardena, MDVM; Rajapakse, S; Herath, J; Amarasena, N
  • Myocardial infarction associated with use of the synthetic cannabinoid K2
    Mir, A; Obafemi, A; Young, A; Kane, C
  • Cardiovascular side effects related with use of “bonzai”: two case reports
    Atik, SU; Dedeoglu, R; Varol, F; Cam, H; Eroglu, AG; Saltik, L
  • K2—not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report
    McKeever, RG; Vearrier, D; Jacobs, D; LaSala, G; Okaneku, J; Greenberg, MI
  • Cardiovascular system effects of marijuana
    Jones, RT
  • Pharmacology and effects of cannabis: a brief review
    Ashton, CH
  • Coronary no-flow and ventricular tachycardia associated with habitual marijuana use
    Rezkalla, SH; Sharma, P; Kloner, RA
  • Coronary vasospasm in an adolescent resulting from marijuana use
    Basnet, S; Mander, G; Nicolas, R
  • Effect of smoking marihuana and of a high-nicotine cigarette on angina pectoris
    Aronow, WS; Cassidy, J
  • Effect of marijuana and placebo-marijuana smoking on psychological state and on psycho-physiological cardiovascular functioning in anginal patients
    Gottschalk, LA; Aronow, WS; Prakash, R
  • An exploratory prospective study of marijuana use and mortality following acute myocardial infarction
    Mukamal, KJ; Maclure, M; Muller, JE; Mittleman, MA
  • Adverse effects of cannabis
    Hall, W; Solowij, N
  • Conjugate deviation of the eyes after Cannabis indica intoxication
    Mohan, H; Sood, GC
  • Cannabis-related hospitalizations: unexpected serious events identified through hospital databases
    Jouanjus, E; Leymarie, F; Tubery, M
  • Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients
    Westover, AN; McBride, S; Haley, RW
  • Heavy cannabis users at elevated risk of stroke: evidence from a general population survey
    Hemachandra, D; McKetin, R; Cherbuin, N; Anstey, KJ
  • Recreational marijuana use and acute ischemic stroke: a population-based analysis of hospitalized patients in the United States
    Rumalla, K; Reddy, AY; Mittal, MK
  • Ischaemic stroke among young people aged 15 to 50 years in Adelaide, South Australia
    Phillips, MC; Leyden, JM; Chong, WK
  • Trends in substance abuse preceding stroke among young adults: a population based study
    Ríos, F; Kleindorfer, DO; Khoury, J
  • Cannabis-related stroke: myth or reality?
    Wolff, V; Armspach, JP; Lauer, V
  • Cannabis-related stroke: case series and review of literature
    Singh, NN; Pan, Y; Muengtaweeponsa, S; Geller, TJ; Cruz-Flores, S
  • Occipital stroke shortly after cannabis consumption
    Finsterer, J; Christian, P; Wolfgang, K
  • Recurrent stroke in a young cannabis user
    Santos, AF; Rodriguez, M; Maré, R; Ferreira, C; Soares-Fernandes, J; Rocha, J
  • Transient ischemic attack in heavy cannabis smokers—how “safe” is it?
    Mouzak, A; Agathos, P; Kerezoudi, E; Mantas, A; Vourdeli-Yiannakoura, E
  • External carotid artery branches involvement in reversible cerebral vasoconstriction syndrome
    Melki, E; Denier, C; Théaudin-Saliou, M; Sachet, M; Ducreux, D; Saliou, G
  • The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients
    Ducros, A; Boukobza, M; Porcher, R; Sarov, M; Valade, D; Bousser, MG
  • Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction a prospective study in 48 consecutive young patients
    Wolff, V; Lauer, V; Rouyer, O; Sellal, F; Meyer, N; Raul, JS
  • Marijuana induced reversible cerebral vasoconstriction syndrome
    Uhegwu, N; Bashir, A; Hussain, M; Dababneh, H; Misthal, S; Cohen-Gadol, A
  • Cerebrovascular perfusion in marijuana users during a month of monitored abstinence
    Herning, RI; Better, WE; Tate, K; Cadet, JL
  • Characteristics and prognosis of ischemic stroke in young cannabis users compared with non-cannabis users
    Wolff, V; Zinchenko, I; Quenardelle, V; Rouyer, O; Geny, B
  • Cannabis-related myocardial infarction and cardioembolic stroke
    Renard, D; Taieb, G; Gras-Combe, G; Labauge, P
  • Multiple cerebral infarcts in a young patient associated with marijuana use
    Volpon, LC; Sousa, CLMM; Moreira, SKK; Teixeira, SR; Carlotti, APCP
  • Can your heart handle the spice: a case of acute myocardial infarction and left ventricular apical thrombus
    Shah, M; Garg, J; Patel, B; Guthier, J; Freudenberger, RS
  • Activation of peripheral CB1 cannabinoid receptors in hemorrhagic shock
    Wagner, JA; Varga, K; Ellis, EF; Rzigalinski, BA; Martin, BR; Kunos, G
  • Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension
    Varga, K; Wagner, JA; Bridgen, DT; Kunos, G
  • Presynaptic cannabinoid CB(1) receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats
    Godlewski, G; Malinowska, B; Schlicker, E
  • Recurrent stress cardiomyopathy with variable regional involvement: insights into etiopathogenetic mechanisms
    Kaushik, M; Alla, VM; Madan, R; Arouni, AJ; Mohiuddin, SM
  • Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle
    Bonz, A; Laser, M; Küllmer, S
  • Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity
    Mukhopadhyay, P; Bátkai, S; Rajesh, M
  • Cardiovascular pharmacology of cannabinoids
    Pacher, P; Bátkai, S; Kunos, G
  • Cardiovascular consequences of marijuana use
    Sidney, S
  • Cannabis use predicts risks of heart failure and cerebrovascular accidents: results from the national inpatient sample
    Kalla, A; Krishnamoorthy, P; Gopalakrishnan, A; Garg, J; Figueredo, V
  • Mid-ventricular variant takotsubo cardiomyopathy associated with cannabinoid hyperemesis syndrome: a case report
    Nogi, M; Fergusson, D; Chiaco, JM
  • Marijuana (cannabis) use is an independent predictor of stress cardiomyopathy in younger men
    Singh, A; Agrawal, S; Fegley, M; Manda, Y; Nanda, S; Shirani, J
  • Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations
    Pacher, P; Mukhopadhyay, P; Mohanraj, R; Godlewski, G; Bátkai, S; Kunos, G
  • Synthetic marijuana induced acute nonischemic left ventricular dysfunction
    Elsheshtawy, M; Sriganesh, P; Virparia, V; Patel, F; Khanna, A
  • An epidemiologic investigation of marijuana- and cocaine-related palpitations
    Petronis, KR; Anthony, JC
  • Dose-response relationships to cannabis in human subjects
    Kiplinger, GF; Manno, JE
  • Fatal cardiac toxicity temporally related to poly-drug abuse
    Daisley, H; Jones-Le Cointe, A; Hutchinson, G; Simmons, V
  • Acute cardiovascular fatalities following cannabis use
    Bachs, L; Mørland, H
  • Cannabis and cocaine: a lethal cocktail triggering coronary sudden death
    Montisci, M; Thiene, G; Ferrara, SD; Basso, C
  • Ectopic atrial rhythm associated with cannabis use
    Fernández- Fernández, FJ; Caínzos-Romero, T; Mesías Prego, A; Sesma, P
  • Sudden unexpected death under acute influence of cannabis
    Hartung, B; Kauferstein, S; Ritz-Timme, S; Daldrup, T
  • Atrial fibrillation and marijuana smoking
    Korantzopoulos, P; Liu, T; Papaioannides, D; Li, G; Goudevenos, JA
  • Alcohol and illicit drug use as precipitants of atrial fibrillation in young adults: a case series and literature review
    Krishnamoorthy, S; Lip, GY; Lane, DA
  • The electrophysiological effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac conduction in man
    Miller, RH; Dhingra, RC; Kanakis, C; Amat-y-Leon, F; Rosen, KM
  • Prolonged cardiac arrest complicating a massive ST-segment elevation myocardial infarction associated with marijuana consumption
    Orsini, J; Blaak, C; Rajayer, S; Gurung, V; Tam, E; Morante, J; Shamian, B; Malik, R
  • Cardiovascular complications induced by cannabis smoking: a case report and review of the literature
    Fisher, BAC; Ghuran, A; Vadamalai, V; Antonios, TF
  • Marijuana smoking is associated with atrial fibrillation
    Korantzopoulos, P
  • Les artérites du Cannabis indica
    Sterne, J; Ducasting, G
  • Critical limb ischemia in a young man: saddle embolism or unusual presentation of thromboangiitis obliterans?
    Bucci, F; Redler, A; Fiengo, L
  • Images in vascular medicine—Buerger’s disease
    Broz, P; Jaeger, KA
  • Peripheral arteritis disease and ischemic strokes in cannabis use: a case report
    Ibrir, M; Ouadahi, N; Hamzaoui, N; Zemmour, D; Ghita, DH; Habouchi, A
  • Buerger’s disease presenting as a testicular mass: a rare presentation of an uncommon disease
    Roberts, JA; Meyer, J-P
  • Cannabis arteritis
    Combemale, P; Consort, T; Denis-Thelis, L; Estival, JL; Dupin, M; Kanitakis, J
  • Cannabis arteritis: review of the literature
    Cottencin, O; Karila, L; Lambert, M; Arveiller, C; Benyamina, A; Boissonas, A; Goudemand, M; Reynaud, M
  • A 22-year-old woman with lower limb arteriopathy: Buerger’s disease, or methamphetamine or cannabis-induced arteritis?
    Leithauser, B; Langheinrich, AC; Rau, WS; Tillmanns, H; Matthias, FR
  • Cannabis arteritis: a new case report and a review of the literature
    Peyrot, I; Garsaud, AM; Saint-Cyr, I; Quitman, O; Sanchez, B; Quist, D
  • Arteriopathies du cannabis: quatre nouveaux cas [Cannabis arteritis: four new cases]
    Cazalets, C; Laurat, E; Cador, B
  • Is thrombangitis obliterans presentation influenced by cannabis addiction?
    Martin-Blondel, G; Koskas, F; Cacoub, P; Sène, D
  • Cannabis arteritis
    Noel, B; Ruf, I; Panizzon, RG
  • Cannabis and tobacco: cofactors favoring juvenile obliterative arteriopathy
    Schneider, F; Abdoucheli-Baudot, N; Tassart, M
  • Cannabis arteritis: ever more important to consider
    Santos, RP; Resende, CI; Vieira, AP; Brito, C
  • Cannabis arteritis revisited—ten new case reports
    Disdier, P; Granel, B; Serratrice, J
  • Migratory superficial thrombophlebitis in a cannabis smoker
    Lee, C; Moll, S
  • Spontaneous renal artery dissection in a cannabis user
    Lou, JY; Randhawa, MS; Hornacek, D; Bajzer, C
  • Central retinal vein occlusion in a young patients following cannabis smoke inhalation
    Corvi, F; Querques, G; Lattanzio, R; Preziosa, C; Parodi, MB; Bandello, F